Related references
Note: Only part of the references are listed.Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium tuberculosis Isolates: A Systematic Review
Elisea Avalos et al.
PLOS ONE (2015)
Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients
Simbarashe P. Zvada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara L. Bastos et al.
CLINICAL INFECTIOUS DISEASES (2014)
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Abdullah Alsultan et al.
DRUGS (2014)
Defining antibiotic resistance-towards international harmonization
Gunnar Kahlmeter
UPSALA JOURNAL OF MEDICAL SCIENCES (2014)
WHO Group 5 Drugs and Difficult Multidrug-Resistant Tuberculosis: a Systematic Review with Cohort Analysis and Meta-Analysis
Kwok-Chiu Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
Kristian Angeby et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
Frederick A. Sirgel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
Fernanda Maruri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja et al.
PLOS MEDICINE (2012)
Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions
Senia Rosales-Klintz et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2012)
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis
Kwok Chiu Chang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
K. A. Angeby et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis
Thomas Schon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates
Zhaogang Sun et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing
Ruiru Shi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis
P Jureen et al.
TUBERCULOSIS (2004)
Share Paper
